Bowfin Acquisition Corporation

Bowfin Acquisition Corp. was a special purpose acquisition company (SPAC) that completed its business combination with Biote (BioTe Medical) in May 2022. Biote is a leading high-growth health and wellness company focused on hormone optimization through bioidentical hormone replacement therapy (BHRT). The company's primary offering is the "Biote Method," which provides medical practitioners with a comprehensive system for treating hormone imbalances using subcutaneous pellet inserts. Biote also offers a line of clinical-grade nutraceuticals designed to support hormone health and overall wellness. Following the merger, the combined entity operates under the Biote name and is publicly traded on the Nasdaq under the symbol BTMD.